[
  {
    "ts": null,
    "headline": "Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows",
    "summary": "Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows",
    "url": "https://finnhub.io/api/news?id=70607baddd4d3f796690940c1da72640976742011c80e28a55fb93fe5b63bb11",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744989600,
      "headline": "Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows",
      "id": 134146416,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows",
      "url": "https://finnhub.io/api/news?id=70607baddd4d3f796690940c1da72640976742011c80e28a55fb93fe5b63bb11"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?",
    "summary": "Although it isn't the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has caught fire in recent years.  Unfortunately, recent developments make Pfizer's prospects in the weight loss market unattractive.  Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound.",
    "url": "https://finnhub.io/api/news?id=f6929e7ae7ac39471a660274d4d73259c071d56344166906fdbe7cddd8f98c8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744978500,
      "headline": "Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?",
      "id": 133964664,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Although it isn't the largest therapeutic area in the pharmaceutical industry, the market for weight loss therapies has caught fire in recent years.  Unfortunately, recent developments make Pfizer's prospects in the weight loss market unattractive.  Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound.",
      "url": "https://finnhub.io/api/news?id=f6929e7ae7ac39471a660274d4d73259c071d56344166906fdbe7cddd8f98c8e"
    }
  },
  {
    "ts": null,
    "headline": "3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever",
    "summary": "As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.",
    "url": "https://finnhub.io/api/news?id=8d4c200267fbd6c51043898c1f6cef67870a4adebf6bedd7a2a4c1b23403bd18",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744959900,
      "headline": "3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever",
      "id": 133964567,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "As tough as it may be to do right now, this is a great time to hold your nose and dive in while yields are as high as they are.",
      "url": "https://finnhub.io/api/news?id=8d4c200267fbd6c51043898c1f6cef67870a4adebf6bedd7a2a4c1b23403bd18"
    }
  },
  {
    "ts": null,
    "headline": "Why Eli Lilly and Company (LLY) is Skyrocketing?",
    "summary": "We recently published a list of 10 Firms End Stronger, Buck Muted Broader Market Trading. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other other firms that ended the week strong. The stock market ended the shortened trading week mixed, with two of the major […]",
    "url": "https://finnhub.io/api/news?id=332bdaa7230d2f40d34b8baa4d1bfc23d7c713647d950f1d0518ffe7e6e2c606",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744957912,
      "headline": "Why Eli Lilly and Company (LLY) is Skyrocketing?",
      "id": 133964506,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Firms End Stronger, Buck Muted Broader Market Trading. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other other firms that ended the week strong. The stock market ended the shortened trading week mixed, with two of the major […]",
      "url": "https://finnhub.io/api/news?id=332bdaa7230d2f40d34b8baa4d1bfc23d7c713647d950f1d0518ffe7e6e2c606"
    }
  }
]